Moreover, as elevated hepatic p53 correlates with hyperglycemia and HOMA-IR in T2DM patients and impairs insulin sensitivity (45), we observed that CUR treatment markedly reduced T2DM-induced p53 phosphorylation. This evidence concerns the gene TP53 and type 2 diabetes mellitus.